2018 대한부정맥학회 심실빈맥 전극도자 절제술 가이드라인 Part 1

참고문헌 (207)

1. Frankel DS, "Ventricular tachycardia ablation remains treatment of last resort in structural heart disease: argument for earlier intervention", J Cardiovasc Electrophysiol, 22, pp.1123~1128 (2011)
2. Watanabe H, "Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans", Nat Med, 15, pp.380~383 (2009)
3. Zipes DP, "ACC", AHA, American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, pp.Circulation, 2006[DOI]
4. Priori SG, "Executive summary: HRS", EHRA, Heart Rhythm, pp.2013, 10[DOI]
5. Fishman GI, "Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop", Circulation, 122, pp.2335~2348 (2010)
6. Niemeijer MN, "Declining incidence of sudden cardiac death from 1990-2010 in a general middle-aged and elderly population : The Rotterdam Study", Heart Rhythm, 12, pp.123~129 (2015)
7. Kuisma M, "Paediatric out-of-hospital cardiac arrests--epidemiology and outcome", Resuscitation, 30, pp.141~150 (1995)
8. Donoghue AJ, "Out-ofhospital pediatric cardiac arrest: an epidemiologic review and assessment of current knowledge", Ann Emerg Med, 46, pp.512~522 (2005)
9. Eckart RE, "Sudden death in young adults : an autopsy-based series of a population undergoing active surveillance", J Am Coll Cardiol, 58, pp.1254~1261 (2011)
10. Maron BJ, "Sudden deaths in young competitive athletes: analysis of 1866deaths in the United States, 1980-2006", Circulation, 119, pp.1085~1092 (2009)
11. Maron BJ, "Incidence and causes of sudden death in U.S. college athletes", J Am Coll Cardiol, 63, pp.1636~1643 (2014)
12. Puranik R, "Sudden death in the young", Heart Rhythm, 2, pp.1277~1282 (2005)
13. Winkel BG, "Nationwide study of sudden cardiac death in persons aged 1-35 years", Eur Heart J, 32, pp.983~990 (2011)
14. Winkel BG, "Sudden cardiac death in children(1-18 years) : symptoms and causes of death in a nationwide setting", Eur Heart J, 35, pp.868~875 (2014)
15. Wellens HJ, "Risk stratification for sudden cardiac death : current status and challenges for the future", Eur Heart J, 35, pp.1642~1651 (2014)
16. Myerburg RJ, "Sudden cardiac death. Structure, function, and time-dependence of risk", Circulation, 85, pp.1~10 (1992)
17. Lloyd-Jones DM, "Framingham risk score and prediction of lifetime risk for coronary heart disease", Am J Cardiol, 94, pp.20~24 (2004)
18. Jouven X, "Predicting sudden death in the population: the Paris Prospective Study I", Circulation, 99, pp.1978~1983 (1999)
19. Friedlander Y, "Family history as a risk factor for primary cardiac arrest", Circulation, 97, pp.155~160 (1998)
20. Dekker LR, "Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients", Circulation, 114, pp.1140~1145 (2006)
21. Kaikkonen KS, "Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event", Circulation, 114, pp.1462~1467 (2006)
22. Bezzina CR, "Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction", Nat Genet, 42, pp.688~691 (2010)
23. Arking DE, "Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals", PLoS Genet, 7, pp.e1002158~ (2011)
24. Moss AJ, "Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction", N Engl J Med, 346, pp.877~883 (2002)
25. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
26. Scott PA, "Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias : a meta-analysis", Eur J Heart Fail, 11, pp.958~966 (2009)
27. Levine YC, "B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias", Heart Rhythm, 11, pp.1109~1116 (2014)
28. Priori SG, "Risk stratification in the long-QT syndrome", N Engl J Med, 348, pp.1866~1874 (2003)
29. Spirito P, "Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy", N Engl J Med, 342, pp.1778~1785 (2000)
30. Middlekauff HR, "Syncope in advanced heart failure : high risk of sudden death regardless of origin of syncope", J Am Coll Cardiol, 21, pp.110~116 (1993)
31. Shen WK, "2017 ACC", AHA, American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2017[DOI]
32. Soteriades ES, "Incidence and prognosis of syncope", N Engl J Med, 347, pp.878~885 (2002)
33. Noda T, "Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract", J Am Coll Cardiol, 46, pp.1288~1294 (2005)
34. Viskin S, "The "shortcoupled"variant of right ventricular outflow ventricular tachycardia:a not-so-benign form of benign ventricular tachycardia", J Cardiovasc Electrophysiol, 16, pp.912~916 (2005)
35. Zimetbaum P, "Evaluation of patients with palpitations", N Engl J Med, 338, pp.1369~1373 (1998)
36. Konigstein M, "Druginduced Brugada syndrome: Clinical characteristics and risk factors", Heart Rhythm, 13, pp.1083~1087 (2016)
37. Basso C, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death", Circulation, 132, pp.556~566 (2015)
38. Nordhues BD, "Bileaflet Mitral Valve Prolapse and Risk of Ventricular Dysrhythmias and Death", J Cardiovasc Electrophysiol, 27, pp.463~468 (2016)
39. Sriram CS, "Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest", J Am Coll Cardiol, 62, pp.222~230 (2013)
40. Huikuri HV, "Sudden death due to cardiac arrhythmias", N Engl J Med, 345, pp.1473~1482 (2001)
41. Krahn AD, "Sentinel symptoms in patients with unexplained cardiac arrest : from the cardiac arrest survivors with preserved ejection fraction registry(CASPER)", J Cardiovasc Electrophysiol, 23, pp.60~66 (2012)
42. Ruwald MH, "The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope : a Danish nationwide study", Europace, 14, pp.1506~1514 (2012)
43. Brugada P1, "A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex", Circulation, 83, pp.1649~1659 (1991)
44. Wellens HJ, "The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex", Am J Med, 64, pp.27~33 (1978)
45. Steinman RT, "Wide QRS tachycardia in the conscious adult. Ventricular tachycardia is the most frequent cause", JAMA, 261, pp.1013~1016 (1989)
46. Elhendy A, "Functional and prognostic significance of exerciseinduced ventricular arrhythmias in patients with suspected coronary artery disease", Am J Cardiol, 90, pp.95~100 (2002)
47. Grady TA, "Prognostic significance of exercise-induced left bundle-branch block", JAMA, 279, pp.153~156 (1998)
48. Pérez-Rodon J, "Prognostic value of the electrocardiogram in patients with syncope:data from the group for syncope study in the emergency room (GESINUR)", Heart Rhythm, 11, pp.2035~2044 (2014)
49. Baldasseroni S, "Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure : a report from the Italian network on congestive heart failure", Am Heart J, 143, pp.398~405 (2002)
50. Buxton AE, "QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators", J Am Coll Cardiol, 46, pp.310~316 (2005)
51. Desai AD, "Prognostic significance of quantitative QRS duration", Am J Med, 119, pp.600~606 (2006)
52. Dhar R, "Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II(MADITII)", Heart Rhythm, 5, pp.807~813 (2008)
53. Freedman RA, "Bundle branch block in patients with chronic coronary artery disease : angiographic correlates and prognostic significance", J Am Coll Cardiol, 10, pp.73~80 (1987)
54. Iuliano S, "QRS duration and mortality in patients with congestive heart failure", Am Heart J, 143, pp.1085~1091 (2002)
55. Kadish A, "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy", N Engl J Med, 350, pp.2151~2158 (2004)
56. Zimetbaum PJ, "Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial", Circulation, 110, pp.766~769 (2004)
57. Costantini O, "The ABCD(Alternans Before Cardioverter Defibrillator)Trial : strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention", J Am Coll Cardiol, 53, pp.471~479 (2009)
58. Monasterio V, "Prognostic value of average T-wave alternans and QT variability for cardiac events in MADIT-II patients", J Electrocardiol, 46, pp.480~486 (2013)
59. Chow T, "Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER(Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients)trial", J Am Coll Cardiol, 52, pp.1607~1615 (2008)
60. Gupta A, "Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events : a meta-analysis", Am Heart J, 163, pp.354~364 (2012)
61. Bloomfield DM, "Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum", Circulation, 110, pp.1885~1889 (2004)
62. Barrett PM, "Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring", Am J Med, 127, pp.95~97 (2014)
63. de Asmundis C, "Comparison of the patient-activated event recording system vs. traditional 24 h Holter electrocardiography in individuals with paroxysmal palpitations or dizziness", Europace, 16, pp.1231~1235 (2014)
64. Linzer M, "Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope", Am J Cardiol, 66, pp.214~219 (1990)
65. Turakhia MP, "Diagnostic utility of a novel leadless arrhythmia monitoring device", Am J Cardiol, 112, pp.520~524 (2013)
66. Bloch Thomsen PE, "Long-termrecording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction : the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction(CARISMA)study", Circulation, 122, pp.1258~1264 (2010)
67. Krahn AD, "Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators", Circulation, 99, pp.406~410 (1999)
68. Solbiati M, "Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope", Cochrane Database Syst. Rev, 4, pp.CD011637~ (2016)
69. Volosin K, "Tachycardia detection performance of implantable loop recorders : results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias", Europace, 15, pp.1215~1222 (2013)
70. Solomon SD, "Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both", N Engl J Med, 352, pp.2581~2588 (2005)
71. Gula LJ, "Ejection fraction assessment and survival : an analysis of the Sudden Cardiac Death in Heart Failure Trial(SCD-HeFT)", Am Heart J, 156, pp.1196~1200 (2008)
72. Rauch B, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guidelineadjusted therapy after myocardial infarction", Circulation, 122, pp.2152~2159 (2010)
73. Coleman GC, "Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis: a systematic review and meta-analysis", JACC Cardiovasc Imaging, 10, pp.411~420 (2016)
74. Di Marco A, "Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and metaanalysis", JACC Heart Fail, 5, pp.28~38 (2017)
75. Greulich S, "CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis", JACC Cardiovasc Imaging, 6, pp.501~511 (2013)
76. Piers SR, "Contrast-enhanced MRI-derived scar patterns and associated ventricular tachycardias in nonischemic cardiomyopathy : implications for the ablation strategy", Circ Arrhythm Electrophysiol, 6, pp.875~883 (2013)
77. White JA, "Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias", Circ Cardiovasc imaging, 5, pp.12~20 (2012)
78. Ahmad T, "Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure", JACC Heart Fail, 2, pp.260~268 (2014)
79. Scott PA, "Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis", Eur J Heart Fail, 11, pp.958~966 (2009)
80. Levine YC, "B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias", Heart Rhythm, 11, pp.1109~1116 (2014)
81. Berger R, "B-type natriuretic peptide predicts sudden death in patients with chronic heart failure", Circulation, 105, pp.2392~2397 (2002)
82. Dumas F, "Emergency PCI in post-cardiac arrest patients without ST-segment elevation pattern : insights from the PROCAT II registry", JACC Cardiovasc Interv, 9, pp.1011~1018 (2016)
83. Cronier P, "Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation", Crit Care, 15, pp.R122~ (2011)
84. Spaulding CM, "Immediate coronary angiography in survivors of out-of-hospital cardiac arrest", N Engl J Med, 336, pp.1629~1633 (1997)
85. Zanuttini D, "Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest", Am J Cardiol, 110, pp.1723~1728 (2012)
86. American College of Emergency Physicians, "2013 ACCF", AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation, J Am Coll Cardiol, pp.2013, 61[DOI]
87. Buxton AE, "Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators", N Engl J Med, 342, pp.1937~1945 (2000)
88. Buxton AE, "Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial", Circulation, 106, pp.2466~2472 (2002)
89. Costantini O, "The ABCD(Alternans Before Cardioverter Defibrillator)Trial : strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention", J Am Coll Cardiol, 53, pp.471~479 (2009)
90. Bourke JP, "Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up : results, optimal stimulation protocol and cost-effective screening", J Am Coll Cardiol, 18, pp.780~788 (1991)
91. Bailey JJ, "Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction", J Am Coll Cardiol, 38, pp.1902~1911 (2001)
92. Schmitt C, "Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers", J Am Coll Cardiol, 37, pp.1901~1907 (2001)
93. Hilfiker G, "Utility of electrophysiological studies to predict arrhythmic events", World J Cardiol, 7, pp.344~350 (2015)
94. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
95. Buxton AE, "A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators", N Engl J Med, 341, pp.1882~1890 (1999)
96. Moss AJ, "Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators", N Engl J Med, 335, pp.1933~1940 (1996)
97. Moss AJ, "Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction", N Engl J Med, 346, pp.877~883 (2002)
98. Bhandari AK, "Electrophysiologic testing in patients with the long QT syndrome", Circulation, 71, pp.63~71 (1985)
99. Giustetto C, "Short QT syndrome : clinical findings and diagnostictherapeutic implications", Eur Heart J, 27, pp.2440~2447 (2006)
100. Giustetto C, "Long-term follow-up of patients with short QT syndrome", J Am Coll Cardiol, 58, pp.587~595 (2011)
101. Mahida S, "Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome", J Am Coll Cardiol, 65, pp.151~159 (2015)
102. Priori SG, "Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia", Circulation, 106, pp.69~74 (2002)
103. Gatzoulis KA, "Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population:reappraisal of the role of programmed ventricular stimulation", Circ Arrhythm Electrophysiol, 6, pp.504~512 (2013)
104. Brembilla-Perrot B, "Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic leftventricular dysfunction as assessed by electrophysiologic testing", J Am Coll Cardiol, 44, pp.594~601 (2004)
105. Garson A Jr, "An international study of 287 patients", Circulation, 87, pp.1866~1872 (1993)
106. Hobbs JB, "Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome", JAMA, 296, pp.1249~1254 (2006)
107. Iribarren C, "Short QT in a cohort of 1.7 million persons: prevalence, correlates, and prognosis", Ann Noninvasive Electrocardiol, 19, pp.490~500 (2014)
108. Kaufman ES, "Risk of death in the long QT syndrome when a sibling has died", Heart Rhythm, 5, pp.831~536 (2008)
109. Kimbrough J, "Clinical implications for affected parents and siblings of probands with long-QT syndrome", Circulation, 104, pp.557~562 (2001)
110. Mazzanti A, "Novel insight into the natural history of short QT syndrome", J Am Coll Cardiol, 63, pp.1300~1308 (2014)
111. Wong JA, "Utility of treadmill testing in identification and genotype prediction in long-QT syndrome", Circ Arrhythm Electrophysiol, 3, pp.120~125 (2010)
112. Walker BD, "Burst bicycle exercise facilitates diagnosis of latent long QT syndrome", Am Heart J, 150, pp.1059~1063 (2005)
113. Waks JW, "Global electric heterogeneity risk score for prediction of sudden cardiac death in the general population : the Atherosclerosis Risk in Communities(ARIC)and Cardiovascular Health(CHS)Studies", Circulation, 133, pp.2222~2234 (2016)
114. Priori SG, "Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers", JAMA, 292, pp.1341~1344 (2004)
115. Priori SG, "Risk stratification in the long-QT syndrome", N Engl J Med, 348, pp.1866~1874 (2003)
116. Wedekind H, "QT interval prolongation and risk for cardiac events in genotyped LQTSindex children", Eur J Pediatr, 168, pp.1107~1115 (2009)
117. Goldenberg I, "Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals", J Am Coll Cardiol, 57, pp.51~59 (2011)
118. Nannenberg EA, "Mortality of inherited arrhythmia syndromes : insight into their natural history", Circ Cardiovasc Genet, 5, pp.183~189 (2012)
119. Vaughan Williams EM, "A classification of antiarrhythmic actions reassessed after a decade of new drugs", J Clin Pharmacol, 24, pp.129~147 (1984)
120. Schleifer JW, "Advances in the pharmacologic treatment of ventricular arrhythmias", Expert Opin Pharmacother, 16, pp.2637~2651 (2015)
121. Kudenchuk PJ, "Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest", N Engl J Med, pp.1711~1722 (2016)
122. Mazzanti A, "Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type3", J Am Coll Cardiol, 67, pp.1053~1058 (2016)
123. Reiter MJ, "Importance of beta blockade in the therapy of serious ventricular arrhythmias", Am J Cardiol, 82, pp.9I~19I (1998)
124. Ellison KE, "Effect of beta-blocking therapy on outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)", Circulation, 106, pp.2694~2699 (2002)
125. Reiken S, "Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure", Circulation, 107, pp.2459~2466 (2003)
126. A randomized trial of propranolol in patients with acute myocardial infarction, "Mortality results", JAMA, 247, pp.1707~1714 (1982)
127. Kontos MC, "Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology's NCDR(R)", Am Heart J, 161, pp.864~870 (2011)
128. Nademanee K, "Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy", Circulation, 102, pp.742~747 (2000)
129. Krittayaphong R, "Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebocontrolled study", Am Heart J, 144, pp.e10~ (2002)
130. Connolly SJ, "Meta-analysis of antiarrhythmic drug trials", Am J Cardiol, 84, pp.90R~93R (1999)
131. Steinberg JS, "Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study", Am Heart J, 142, pp.520~529 (2001)
132. Farré J, "Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials", Am J Cardiol, 83, pp.55D~63D (1999)
133. Bardy GH, "Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure", N Engl J Med, 352, pp.225~237 (2005)
134. Thomas KL, "Amiodarone use after acute myocardial infarction complicated by heart failure and", or left ventricular dysfunction may be associated with excess mortality, 2008, pp.155, 87~93
135. Claro JC, "Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death", Cochrane Database Syst. Rev, 12, pp.CD008093~ (2015)
136. Epstein AE, "Practical management guide for clinicians who treat patients with amiodarone", Am J Med, 129, pp.468~475 (2016)
137. Kühlkamp V, "Suppression of sustained ventricular tachyarrhythmias : a comparison of d, lsotalol with no antiarrhythmic drug treatment", J Am Coll Cardiol, 33, pp.46~52 (1999)
138. Waldo AL, "Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction : rationale, design, and methods(the SWORD trial)", Am J Cardiol, 75, pp.1023~1027 (1995)
139. Page RL, "Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function", Am J Cardiol, 85, pp.1481~1485 (2000)
140. Buxton AE, "Hazards of intravenous verapamil for sustained ventricular tachycardia", Am J Cardiol, 59, pp.1107~1110 (1987)
141. Belhassen BHorowitz LN, "Use of intravenous verapamil for ventricular tachycardia", Am J Cardiol, 54, pp.1131~1133 (1984)
142. Griffith MJ, "Effects of intravenous adenosine on verapamil-sensitive"idiopathic"ventricular tachycardia", Am J Cardiol, 73, pp.759~764 (1994)
143. Gill JS, "Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology", Am Heart J, 126, pp.1126~1133 (1993)
144. Badhwar N, "Idiopathic ventricular tachycardia : diagnosis and management", Curr Probl Cardiol, 32, pp.7~43 (2007)
145. Gill JS, "Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia", Pacing Clin Electrophysiol, 15, pp.2122~2126 (1992)
146. Investigators in the Magnesium in Coronaries(MAGIC)Trial, "Early administration of intravenous magnesium to high risk patients with acute myocardial infarction in the Magnesium in Coronaries(MAGIC)Trial : a randomized controlled trial", Lancet, 360, pp.1189~1196 (2002)
147. Cooper HA, "Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction", Circulation, 100, pp.1311~1315 (1999)
148. Kafka H, "Serum magnesium and potassium in acute myocardial infarction. Influence on ventricular arrhythmias", Arch Intern Med, 147, pp.465~469 (1987)
149. Tzivoni D, "Treatment of torsade de pointes with magnesium sulfate", Circulation, 77, pp.392~397 (1988)
150. Leier CV, "Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure : hyponatremia, hypokalemia, and hypomagnesemia", Am Heart J, 128, pp.564~574 (1994)
151. Yancy CW, "2016 ACC", AHA, AHA guideline for the management of heart failure : a report of the American College of Cardiology, pp.American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America, J Am Coll Cardiol[DOI]
152. Committees for Cardiac insufficiency Bisoprolol Study II, "The cardiac insufficiency Bisoprolol Study II(CIBIS-II) : a randomised trial", Lancet, 353, pp.9~13 (1999)
153. Cohn JN, "A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure", N Engl J Med, 325, pp.303~310 (1991)
154. Packer M, "The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group", N Engl J Med, 334, pp.1349~1355 (1996)
155. Dargie HJ, "Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction : the CAPRICORN randomised trial", Lancet, 357, pp.1385~1390 (2001)
156. Pitt B, "Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction", N Engl J Med, 348, pp.1309~1321 (2003)
157. Al Chekakie MO, "Traditional heart failure medications and sudden cardiac death prevention: a review", J Cardiovasc.Pharmacol Ther, 18, pp.412~426 (2013)
158. Pfeffer MA, "Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both", N Engl J Med, 349, pp.1893~1906 (2003)
159. Hjalmarson A, "Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR", XL Randomized Intervention Trialin congestive heart failure (MERIT-HF). MERIT-HF Study Group, 2000, pp.283, 1295~1302
160. McMurray JJ, "Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors : the CHARM-Added trial", Lancet, 362, pp.767~771 (2003)
161. Pitt B, "The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators", N Engl J Med, 341, pp.709~717 (1999)
162. Zannad F, "Eplerenone in patients with systolic heart failure and mild symptoms", N Engl J Med, 364, pp.11~21 (2011)
163. Desai AS, "Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients", Eur Heart J, 36, pp.1990~1997 (2015)
164. Zafari AM, "A program encouraging early defibrillation results in improved inhospital resuscitation efficacy", J Am Coll Cardiol, 44, pp.846~852 (2004)
165. Link MS, "Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care", Circulation, 132, pp.S444~S464 (2015)
166. 대한심폐소생협회, "2015 심폐소생술 가이드라인 (2015 Korean Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care). 제 3부 전문심장소생술", pp.80~166 (2015)
167. Dorian P, "Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation", N Engl J Med, 346, pp.884~890 (2002)
168. Kudenchuk PJ, "Amiodarone, lidocaine, or placebo in out-of-hospital cardiac arrest", N Engl J Med, 374, pp.1711~1722 (2016)
169. Kudenchuk PJ, "Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation", N Engl J Med, 341, pp.871~878 (1999)
170. Gill JS, "Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology", Am Heart J, 126, pp.1126~1133 (1993)
171. Belhassen B, "Response of recurrent sustained ventricular tachycardia to verapamil", Br Heart J, 46, pp.679~682 (1981)
172. Sami Viskin, "Idiopathic Polymorphic Ventricular Tachycardia: a “Benign Disease” with a Touch of Bad Luck?", Korean Circulation Journal, 47(3), pp.299~306 (2017), 대한심장학회
173. Gorgels AP, "Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia", Am J Cardiol, 78, pp.43~46 (1996)
174. Markel DT, "Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest", Acad Emerg Med, 17, pp.617~623 (2010)
175. Ortiz M, "intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia : the PROCAMIO study", Eur Heart J, 38, pp.1329~1335 (2017)
176. Nasir N Jr, "Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction", Am J Cardiol, 74, pp.1183~1186 (1994)
177. Joglar JA, "Out-of-hospital cardiac arrest--are drugs ever the answer", N Engl J Med, 374, pp.1781~1782 (2016)
178. Teo KK, "Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials", JAMA, 270, pp.1589~1589 (1993)
179. Nademanee K, "Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy", Circulation, 102, pp.742~747 (2000)
180. Registry), "Am J Cardiol", 2008, 1427~1432
181. Thel MC, "Randomized trial of magnesium in in-hospital cardiac arrest. Duke Internal Medicine House staff", Lancet, 350, pp.1272~1276 (1997)
182. Hassan TB, "A randomized trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation", Emerg Med J, 19, pp.57~62 (2002)
183. Elizari MV, "Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicentricos en Argentina", Eur Heart J, 21, pp.198~205 (2000)
184. Buxton AE, "Hazards of intravenous verapamil for sustained ventricular tachycardia", Am J Cardiol, 59, pp.1107~1110 (1987)
185. Somberg JC, "Intravenous lidocaine versus intravenous amiodarone(in a new aqueous formulation)for incessant ventricular tachycardia", Am J Cardiol, 90, pp.853~859 (2002)
186. Tomlinson DR, "Intravenous amiodarone for the pharmacological termination ofhaemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment", Emerg Med J, 25, pp.15~18 (2008)
187. Ho DS, "Doubleblind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia", Lancet, 344, pp.18~23 (1994)
188. Griffith MJ, "Effects of intravenous adenosine on verapamil-sensitive"idiopathic"ventricular achycardia", Am J Cardiol, 73, pp.759~764 (1994)
189. Carbucicchio C, "Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators : short-and long-term outcomes in a prospective single-center study", Circulation, 117, pp.462~469 (2008)
190. Reddy VY, "Prophylactic catheter ablation for the prevention of defibrillator therapy", N Engl J Med, 357, pp.2657~2665 (2007)
191. Kuck KH, "Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial", Lancet, 375, pp.31~40 (2010)
192. Connolly SJ, "Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial", JAMA, 295, pp.165~171 (2006)
193. de Chillou C, "Isthmus characteristics of reentrant ventricular tachycardia after myocardial infarction", Circulation, 105, pp.726~731 (2002)
194. Berruezo A, "Electrocardiographic recognition of the epicardial origin of ventricular tachycardias", Circulation, 109, pp.1842~1847 (2004)
195. Haissaguerre M, "Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes", Circulation, 108, pp.925~928 (2003)
196. Perez-David E, "Noninvasive identification of ventricular tachycardia-related conducting channels using contrast-enhanced magnetic resonance imaging in patients with chronic myocardial infarction : comparison of signal intensity scar mapping and endocardial voltage mapping", J Am Coll Cardiol, 57, pp.184~194 (2011)
197. Jais P, "Elimination of local abnormal ventricular activities : a new end point for substrate modification in patients with scar-related ventricular tachycardia", Circulation, 125, pp.2184~2196 (2012)
198. Di Biase L, "Endo-epicardial homogenization of the scar versus limited substrate ablation for the treatment of electrical storms in patients with ischemic cardiomyopathy", J Am Coll Cardiol, 60, pp.132~141 (2012)
199. Dinov B, "Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy : results from the Prospective Heart Centre of Leipzig VT(HELP-VT)Study", Circulation, 129, pp.728~736 (2014)
200. Stevenson WG, "Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction : the multicenter thermocool ventricular tachycardia ablation trial", Circulation, 118, pp.2773~2782 (2008)
201. Reddy VY, "Prophylactic catheter ablation for the prevention of defibrillator therapy", N Engl J Med, 357, pp.2657~2665 (2007)
202. Kuck KH, "Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease(VTACH) : a multicentre randomised controlled trial", Lancet, 375, pp.31~40 (2010)
203. Tokuda M1, "Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance", J Am Heart Assoc, 2, pp.e000072~ (2013)
204. Della Bella P, "Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias : long-term outcome after ablation", Circulation, 127, pp.1359~1368 (2013)
205. Peichl P, "Complications of catheter ablation of ventricular tachycardia : a single-center experience", Circ Arrhythm Electrophysiol, 7, pp.684~690 (2014)
206. Yamada T, "Radiofrequency catheter ablation of idiopathic ventricular arrhythmias originating from intramural foci in the left ventricular outflow tract : efficacy of sequential versus simultaneous unipolar catheter ablation", Circ Arrhythm Electrophysiol, 8, pp.344~352 (2015)
207. Nogami A, "Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia", J Am Coll Cardiol, 36, pp.811~823 (2000)

관련 논문AI추천